Trustees of Columbia University in the City of New York’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Trustees of Columbia University in the City of New York’s Portfolio EVLO Stock Details EVLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-5,693	Closed	-$20.6K	–	19
2023 Q1	$20.6K	Hold	5,693	–	–	0.04%	16
2022 Q4	$183K	Buy	+5,693	New	+$225K	0.38%	14
2021 Q3	$802K	Hold	5,693	–	–	1.23%	13
2021 Q2	$1.56M	Hold	5,693	–	–	2.31%	7
2021 Q1	$1.22M	Hold	5,693	–	–	1.48%	8
2020 Q4	$1.38M	Buy	+5,693	New	+$704K	1.84%	6

Other funds holding EVLO

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

SOMRS

State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trustees of Columbia University in the City of New York's EVLO Position: Q2 2023 in Review

Trustees of Columbia University in the City of New York sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2023, closing a stake of 5,693 shares — an estimated $20.6K sold.

Trustees of Columbia University in the City of New York first reported a position in EVLO in Q4 2020 and held it in 6 quarters. The position peaked at $1.56M in Q2 2021. 25 funds tracked by Wall St. Rank hold EVLO as of Q2 2023.

Trustees of Columbia University in the City of New York reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Trustees of Columbia University in the City of New York sold 5,693 Evelo Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $20.6K.
Trustees of Columbia University in the City of New York first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Trustees of Columbia University in the City of New York's Evelo Biosciences, Inc. Common Stock position peaked at $1.56M in Q2 2021.
25 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2023.

Based on Trustees of Columbia University in the City of New York's 13F filing for Q2 2023, filed 14 Aug 2023.